We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$20B
AUM Growth
+$1.88B
Cap. Flow
+$1.7B
Cap. Flow %
8.49%
Top 10 Hldgs %
14%
Holding
1,901
New
565
Increased
401
Reduced
415
Closed
510

Sector Composition

Rank Sector Weight
1 Healthcare 21.2%
2 Consumer Discretionary 15.25%
3 Technology 14.69%
4 Industrials 11.95%
5 Financials 11.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPRO icon
1351
Expro Ltd
XPRO
$1.91B
$147K ﹤0.01%
+4,510
New +$175K
SUP
1352
DELISTED
Superior Industries International
SUP
$146K ﹤0.01%
10,951
OSBC icon
1353
Old Second Bancorp
OSBC
$1.29B
$143K ﹤0.01%
+10,275
New +$146K
SREV
1354
DELISTED
ServiceSource International, Inc.
SREV
$143K ﹤0.01%
+37,424
New +$134K
XONE
1355
DELISTED
The ExOne Company
XONE
$143K ﹤0.01%
+19,656
New +$176K
ARAY icon
1356
Accuray
ARAY
$34M
$139K ﹤0.01%
+27,782
New +$146K
CDNA icon
1357
CareDx
CDNA
$2.42B
$138K ﹤0.01%
+17,359
New +$107K
ASYS icon
1358
Amtech Systems
ASYS
$272M
$137K ﹤0.01%
+18,766
New +$169K
SOGO
1359
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$134K ﹤0.01%
16,278
-555,266
-97% -$5.64M
VSTM icon
1360
Verastem
VSTM
$610M
$132K ﹤0.01%
3,678
-19,043
-84% -$738K
HABT
1361
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
$130K ﹤0.01%
14,829
+792
+6% +$7.14K
MR
1362
DELISTED
Montage Resources Corporation Common Stock
MR
$128K ﹤0.01%
+5,913
New +$170K
ONSIW
1363
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$125K ﹤0.01%
125,400
EMWP
1364
DELISTED
Eros Media World PLC
EMWP
$124K ﹤0.01%
+571
New +$136K
AGI icon
1365
Alamos Gold
AGI
$13.9B
$118K ﹤0.01%
+22,606
New +$127K
TRVG
1366
trivago
TRVG
$397M
$116K ﹤0.01%
+3,343
New +$132K
EXPR
1367
DELISTED
Express, Inc.
EXPR
$111K ﹤0.01%
+777
New +$115K
NG icon
1368
NovaGold Resources
NG
$3.33B
$102K ﹤0.01%
23,563
-185,620
-89% -$744K
NPTN
1369
DELISTED
NEOPHOTONICS CORP
NPTN
$94K ﹤0.01%
+13,767
New +$87.4K
DHT icon
1370
DHT Holdings
DHT
$3.02B
$88K ﹤0.01%
+25,748
New +$95.6K
VRDN icon
1371
Viridian Therapeutics
VRDN
$2.67B
$85K ﹤0.01%
+807
New +$87.7K
CALA
1372
DELISTED
Calithera Biosciences, Inc
CALA
$83K ﹤0.01%
+657
New +$102K
BKD icon
1373
Brookdale Senior Living
BKD
$3.4B
$82K ﹤0.01%
+12,245
New +$103K
GNMK
1374
DELISTED
GenMark Diagnostics, Inc
GNMK
$79K ﹤0.01%
14,544
OTIC
1375
DELISTED
Otonomy, Inc.
OTIC
$78K ﹤0.01%
18,606
-105,816
-85% -$576K

Similar funds

Marshall Wace North America's Q1 2018 Portfolio in Review

As of Q1 2018, Marshall Wace North America held 1,901 positions worth $20B, up 10% from $18.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.7B of net new capital in Q1 2018, opening 565 new positions and adding to 401 existing holdings. Its largest new stake was Citigroup: 2,429,984 shares worth $164M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $285M trimmed.

  • Marshall Wace North America's largest Q1 2018 buy was Citigroup: 2,429,984 shares worth $164M.
  • Marshall Wace North America added most to Microsoft in Q1 2018, an estimated $328M increase.
  • Marshall Wace North America's biggest Q1 2018 reduction was Alphabet (Google) Class A, cutting an estimated $285M.
  • Marshall Wace North America fully exited Manulife Financial in Q1 2018, selling an estimated $83.9M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $20B portfolio in Q1 2018.
  • Marshall Wace North America opened 565 new positions and closed 510 in Q1 2018.
  • Marshall Wace North America's portfolio value rose 10% quarter-over-quarter to $20B.

Based on Marshall Wace North America's 13F filing for Q1 2018, filed 15 May 2018.